Voloridge Investment Management
CNTA

Voloridge Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Voloridge Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.45M Sell
111,956
-236,323
-68% -$6.04M 0.02% 695
2025
Q4 		$8.71M Buy
+348,279
New +$8.82M 0.03% 628
2025
Q3 		– Sell
-39,379
Closed -$517K – 1213
2025
Q2 		$517K Buy
+39,379
New +$499K ﹤0.01% 1079

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Voloridge Investment Management's CNTA Position: Q1 2026 in Review

Voloridge Investment Management reduced its Centessa Pharmaceuticals (CNTA) stake by 68% in Q1 2026, selling an estimated $6.04M and leaving 111,956 shares worth $4.45M. The position accounts for 0.02% of the portfolio, ranked #695.

Voloridge Investment Management first reported a position in CNTA in Q2 2025 and has held it in 3 quarters since. The position peaked at $8.71M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Voloridge Investment Management held 111,956 shares of Centessa Pharmaceuticals worth $4.45M as of Q1 2026.
  • Voloridge Investment Management sold 236,323 Centessa Pharmaceuticals shares in Q1 2026, an estimated $6.04M.
  • Centessa Pharmaceuticals made up 0.02% of Voloridge Investment Management's portfolio in Q1 2026, its #695 holding.
  • Voloridge Investment Management first reported a position in Centessa Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Voloridge Investment Management's Centessa Pharmaceuticals position peaked at $8.71M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.